CN Patent

CN101743316A — 用于获得11-脱氧皮醇的17α-单酯和/或其9,11-脱氢衍生物的酶法

Assigned to Cassiopea SpA · Expires 2010-06-16 · 16y expired

What this patent protects

本发明涉及用于从相应的17α，21-二酯起始获得11-脱氧皮醇的17α-单酯和/或其9，11-脱氢衍生物的酶法，所述酶法包括酶的醇解反应。此外，本发明涉及11-脱氧皮醇17α-丙酸酯和9，11-脱氢-11-脱氧皮醇17α-丁酸酯的晶型。

USPTO Abstract

本发明涉及用于从相应的17α，21-二酯起始获得11-脱氧皮醇的17α-单酯和/或其9，11-脱氢衍生物的酶法，所述酶法包括酶的醇解反应。此外，本发明涉及11-脱氧皮醇17α-丙酸酯和9，11-脱氢-11-脱氧皮醇17α-丁酸酯的晶型。

Drugs covered by this patent

Patent Metadata

Patent number
CN101743316A
Jurisdiction
CN
Classification
—
Expires
2010-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Cassiopea SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.